SMI-32 immunoreactivity in human striate cortex during postnatal development.
SMI-32, an antibody which recognizes the non-phosphorylated epitopes on the neurofilament proteins was used to study the morphological changes in the human striate cortex during postnatal development. Striate cortices from 12 autopsied patients with ages ranging from 1 day to 70 years were obtained. Using the avidin-biotin-peroxidase method, the first SMI-32 immunoreactive neurons were identified at sublayers Vb/VIa on the first postnatal day. At 5 months, the next group of neurons to develop immunoreactivity were in IVb. By 15 months, SMI-32 immunoreactive neurons were observed at III, IVa, IVb, V and VI. The changes in SMI-32 immunoreactivity (ir) were stabilized from 3 years and after. The SMI-32 ir in the striate cortex could be a useful morphological correlate for studying developmental diseases affecting the neocortex.
Ang
L C
LC
Department of Pathology [Neuropathology], University of Saskatchewan, Saskatoon, Canada.
Munoz
D G
DG
Shul
D
D
George
D H
DH
D000328:Adult; D000375:Aging; D000911:Antibodies, Monoclonal; D001344:Autopsy; D002648:Child; D002675:Child, Preschool; D000939:Epitopes / Q000032:analysis; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D016900:Neurofilament Proteins / Q000032:analysis* / Q000276:immunology; D009474:Neurons / Q000473:pathology / Q000502:physiology; D014793:Visual Cortex / Q000254:growth & development* / Q000473:pathology
D000911:Antibodies, Monoclonal; D000939:Epitopes; D016900:Neurofilament Proteins